Celadon Pharmaceuticals (CEL)

Sector:

Alternative Investment Instruments

Index:

FTSE AIM All-Share

 100.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 172.50
  • 52 Week Low: 79.00
  • Currency: UK Pounds
  • Shares Issued: 65.74m
  • Volume: 0
  • Market Cap: 65.74m
  • RiskGrade: 111

CEL Overview

Celadon Pharmaceuticals Plc is a United Kingdom-based pharmaceutical company. The Company is engaged in research, cultivation, manufacturing and supply of cannabinoid-based medicines. The Company is focused on growing indoor hydroponic cannabis initially for the chronic pain market. It is also focused on improving the quality of life for chronic pain sufferers, as well as exploring the potential of cannabinoid-based medicines for other conditions, such as autism and multiple sclerosis. The Company's facility comprises an indoor, closed-loop hydroponic system to ensure cannabis plants are cultivated under a highly specific climate, light and with irrigation control.

1 Day Chart (22-05-2024)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -7908.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 876.6 n/a
Pr/Book 20.7  
Latest F'cast
Revenue 212.5% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

CEL Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Aug-19 n/a (0.19) (3.60)p n/a n/a n/a n/a 0.0%
31-Aug-20 n/a (0.17) (2.85)p n/a n/a n/a n/a 0.0%
31-Dec-21 n/a (4.80) (7.87)p n/a n/a n/a n/a 0.0%
31-Dec-22 0.02 (18.12) (29.70)p n/a n/a n/a n/a 0.0%
31-Dec-23 0.07 (7.52) (11.50)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest CEL Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

CEL Market Data

Currency UK Pounds
Share Price 100.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 172.50
52 Week Low 79.00
Volume 0
Shares Issued 65.74m
Market Cap 65.74m
RiskGrade 111

CEL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
Market averageMarket averageMarket averageMarket averageMarket average
93.22% below the sector average93.22% below the sector average93.22% below the sector average93.22% below the sector average93.22% below the sector average
Price Trend
Market averageMarket averageMarket averageMarket averageMarket average
39.68% below the sector average39.68% below the sector average39.68% below the sector average39.68% below the sector average39.68% below the sector average
Income Not Available
Growth
Market averageMarket averageMarket averageMarket averageMarket average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average

CEL Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

CEL Key Personnel

CEO James Short
CFO Jonathan Turner

Top of Page